Abstract Background There is increasing international recognition that populations included in trials should adequately represent the population treated in clinical practice; however. adults who lack the capacity to provide informed consent are frequently excluded from trials. Addressing the under-representation of groups such as those with impaired capacity to consent is essential to... https://fitnessgravesyardes.shop/product-category/hub/